For BRCA2, there were 28 of 421 PPCs (6.7%—range 36‐87, median 63 years) slightly older than all BRCA2 ovarian cancers (range 32‐89 years, median 58.0 years). This evidence concerns the gene BRCA2 and ovarian carcinoma.